Updated Bayesian Network Meta-Analysis of Adjuvant Targeted Treatment Regimens for Early Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer

PURPOSE: Combining targeted agents with adjuvant chemotherapy prolongs survival in human epidermal growth factor receptor 2 (HER2)-positive breast cancer patients, but also increases the risk of adverse effects. The updated results of 3 randomized controlled trials (RCTs) were reported in 2019. Give...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Breast Cancer
Autori principali: Li, Xinyan, Yao, Litong, Wang, Mozhi, Wang, Mengshen, Li, Xiang, Yu, Xueting, Guo, Jingyi, Dong, Haoran, Sun, Xiangyu, Xu, Yingying
Natura: Artigo
Lingua:Inglês
Pubblicazione: Korean Breast Cancer Society 2020
Soggetti:
Original Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC7462812/
https://ncbi.nlm.nih.gov/pubmed/32908791
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4048/jbc.2020.23.e45
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi